Arcus Biosciences: Leerink Partners raises target price to $49 from $46
RCUS•Leerink Partners raised its target price for Arcus Biosciences to $49 from $46.
Related News
BD raises quarterly dividend 1% to $1.06 per share
BDX•
Cencora: BofA Global Research raises price objective to $360 from $345
COR•
Aspen Aerogels Q3 2026 net loss widens 64% year-over-year to $10.42 million
ASPN•
Block, Inc.: Wells Fargo raises target price to $110 from $97
XYZ•
Chatham Lodging Q3 net income more than triples to $5.27 million; revenue rises 16% to $90.92 million
CLDT•